Emerging Endoluminal Bariatric Techniques
|
|
- Georgiana Harrell
- 5 years ago
- Views:
Transcription
1 Session IV UGS-IV: Emerging but rarely Used Treatment Options in Asia Emerging Endoluminal Bariatric Techniques Jacques Devière, M.D., Ph.D. Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium Introduction Obesity is clearly the pandemic of the 21 st century and is associated with considerable morbidity and mortality 1. Management of obesity depends on body mass index (BMI) as well as the presence of co morbidities, including heart disease, diabetes, hypertension, dyslipidemia, osteoarthritis, and sleep apnea. 2 Approximately 1.6 billion adults are overweight; at least 400 million adults are obese. World Health Organization (WHO) further projects that by 2015, approximately 2.3 billion adults will be overweight and more than 700 million will be obese. Once considered a problem only in high income countries, overweight and obesity are now dramatically on the rise in low and middle income countries, particularly in urban settings. 3 The only effective therapy for morbid obesity, as defined by Body Mass Index (BMI) of 40 kg/m 2 or more, or by a BMI of 35 kg/m 2 or more in the presence of co morbidities, is currently surgery 4. It has been shown effective on the long term and significantly reduces the risk of mortality associated with this disease. In the US, the number of indications for bariatric surgery has increased by 80% between 1998 and and in terms of health care demand, it clearly will represent the pandemic of the 21 st century. Bariatric surgery for morbidly obese patients has demonstrated significant clinical benefits. It induces and maintains satisfactory weight loss while decreasing co morbidities associated with the patient s overweight. 6 Efficacy varies with the type of procedure, which can be divided into restrictive (lap band, vertical gastroplasty, sleeve gastrectomy), malabsorptive (biliopancreatic diversion) or a combination of both (gastric by pass). The first and the latter type of operations are currently the most frequently performed sometimes as an optional 2 steps procedure starting with gastric restriction. Although very effective, laparoscopic and surgical bariatric procedures have complication rates of 3% to 20% and mortality rates of 1%. 7 Cardiopulmonary events and anastomotic leaks are the major sources of severe morbidities. The demand for less invasive therapy for obesity in the last years lead to emergence of endoscopic technology potentially characterized by less invasiveness and less post procedures complications. Indeed, endoluminal surgery, performed entirely through natural orifice, offers the potential for a less invasive weight loss procedure, possibly performed on an ambulatory basis, and might find its place in the current armamentarium or morbid obesity treatment, extending indication to patients with severe co morbidities, older age or even non morbid obese patients. We review the various endoluminal techniques which are currently ei- 114 IDEN 2014
2 UGS-IV: Emerging but rarely Used Treatment Options in Asia ther in routine use or in clinical evaluation, and will also address the role of endoscopy in management of complications occurring after bariatric surgery. Endoscopic options for endoluminal primary treatment of obesity. 1. Intragastric Balloon. The use of intragastric device to induce weight loss in obese patients was first described in Since then, numbers of intragastric balloons have been in use worldwide, and several have been withdrawn from the market. With a spherical shape and larger capacity than earlier models, the BioEnterics Intragastric Balloon (BIB, Allergan, Irvine, CA) is the one which has been the most extensively studied. Among the recently improved minimally invasive procedures, intragastric balloon has been one temporary nonsurgical option that can promote weight loss in obese patients by partially filling their stomach and inducing a sense of early satiety. 9,10 One of the major drawbacks of balloon implantation is weight regain after balloon removal. In this line, two recent studies help to better understand what can be expected from balloon implantation. Mathus Vliegen et al 11 included patients who had participated in a randomized controlled trial comparing balloon versus sham for a 3 months period, into an additional trial including 9 months of balloon treatment and follow up for 1 year after removal. They excluded 8 patients who had not met the weight loss goal during the first 3 months (N=5) or who did not tolerate the balloon (N=3). Although there was no difference between sham and balloon during the first 3 months, after 1 year of balloon treatment, a mean weight loss of 21.3 kg (17.1%) was achieved in all patients of which 12.6 kg (9.9%) was maintained at the end of the second balloon free year. Overall, 47% of patients sustained a 10% weight loss at the end of 2 years follow up. Although this study could not demonstrate an independent benefit of balloon treatment beyond diet, exercise, and behavioral therapy in the first treatment, balloon treatment for 1 year, in those patients who tolerated the treatment, resulted in substantial weight loss, a significant part of which was maintained during the first year after removal of the balloon. Another recently published study looked at the long term outcome after treatment with an intragastric balloon for 6 months, with no structured weight maintenance program after balloon removal. Hundred consecutive morbidly obese individuals were prospectively followed after BIB placement (Allergan, Irvine, CA) ; 97 patients completed final follow up at a mean of 4.8 years. While, after 6 months, 63% of patients had more than 10% baseline weight loss, there were only 28% at final follow up. At that time, 35 patients had undergone bariatric surgery and 34 patients had no significant weight change from baseline. 12 These studies further confirm that balloon implantation may be of some help in a minority of patients for long term weight loss. It is a potential option for patients unwilling bariatric surgery or not candidate for bariatric surgery, and could also be used as a temporary measure in super obese patients, in order to induce weight loss and decrease the risk of complications associated with further bariatric surgery Gastric Restriction. A. Endoluminal vertical gastroplasty using EndoCinch The EndoCinch Suturing System (C.R. Bard, Murray Hill, NJ) was initially designed for the endoscopic treat- IDEN
3 IDEN 2014 ment of GERD. This system allows the placement of series of stitches in the lower esophagus to create a pleat in the sphincter. This pleat alters the gateway between the stomach and esophagus and potentially prevents acid from flowing out of the stomach. Although associated with encouraging early results, the EndoCinch for the treatment of GERD has been called into questions due to the lack of retention of plications in the long term. 14 Fogel et al 15 first described the use of this technology for the treatment of obesity in 64 patients. His technique consisted in the deployment of 7 sutures in a continuous and cross linked design from the proximal fundus to the distal body. The result of the treatment is suggested to be a significant decrease in distensibility of the stomach. The procedure was performed ambulatory and out of the 59 patients followed for 12 months, the percentage excess weight loss reported was 21% at 1 month and 58% at 12 months. Only a minority of patients (N=14) underwent repeated endoscopy in the follow up. In 11 of them, the suture line was reported as completely or partially intact. A randomized controlled trial is ongoing in the US to further investigate this technique and hopefully will also provide long term data that are the major matter of concern both clinically and anatomically. B. Transoral gastroplasty Transoral gastroplasty (TOGa System; Satiety, Inc, Palo Alto, CA) recently emerged as a new and apparently safe technique for the endoluminal surgical treatment of obesity. It uses the first endoscopic stapling device in Transoral gastroplasty device (TOGA system) Stapling procedure Vertical staple line Device positioned into the stomach, with a sliding sleeve separating posterior and anterior walls before vacuum tissue acquisition and stapling Endoscopic view after placement of 2 staples lines 1 month follow up Fig. 1. Transoral gastroplasty procedure. 116 IDEN 2014
4 UGS-IV: Emerging but rarely Used Treatment Options in Asia order to create a full thickness plication in the proximal stomach, with a strictly endoluminal approach. The purpose is, like for other restrictive procedures, to induce an early satiety due to the reduction of the stomach capacity. The system consists of the TOGa Sleeve Stapler, a flexible 18 mm diameter shaft device, which rides over a guide wire for introduction. It is specifically designed for the procedure and accommodates a standard endoscope up to 8.6 mm diameter and creates a full thickness plication of the anterior and posterior walls of the stomach, which are acquired using vacuum pots located parallel to the staple line (Fig. 1). The stapling allows a serosa to serosa apposition and is performed via 2 successive applications of staple lines of 5 cm each. In the first evaluation, this procedure is completed by the placement of restriction in the distal part of the pouch, using a dedicated stapling device also based on vacuum acquisition of the tissues. Only 2 human series are currently published as full paper. The first one 16 was performed in 21 patients with a mean BMI of 43.3 kg/m². The mean excess weight loss was 16, 23 and 25% at 1, 3 and 6 months post treatment. No severe adverse event was reported and, at 6 months endoscopy, Gaps between the 2 staple lines were evidenced in 13 of 21 patients. After this first evaluation, the technique was improved, especially concerning the successive application of the 2 staple lines and the device has been modified. Using this later, a second human pilot series 17 was reported in 11 patients, showing better results with mean excess weight loss of 19, 34 and 46% at 1, 3 and 6 months, respectively. Another 300 patients were included in a multicentric randomized sham controlled trial. This study showed a significant but modest advantage over the sham procedure but was judged insufficient by the FDA, a feature which led to closure of the company. The interest of these studies was however to show that these transoral techniques are not more difficult to perform in heavily obese patients and recovery is very fast and the procedure could be performed on an outpatient basis. The revisional surgery after TOGa was evaluated in a recent study showing that the conversion of TOGa into a laparoscopic Roux en Y gastric bypass (LRYGBP) was easy and performed over the same duration as a primary LRYGBP, without the excess time and difficulty usually needed for conversion of a restrictive procedure into a LRYGBP. 18 C. The POSE procedure The POSE (USGI medical, USA) procedure includes a multi lumen access device, an endoluminal tissue approximator and suture anchors and consists in performing multiple transmural plicatures into the fundus and the distal body of the stomach (Fig. 2). The first pilot study 19 included 45 patients with an initial BMI of 37. As an outpatient procedure with a mean OR time of 1 hour, the authors achieved a 49% EWL at 6 months. Larger randomized studies are awaited to evaluate the time efficacy of this promising technique. D. Duodenojejunal bypass sleeve. This technique has to be put in line with the development of metabolic surgery and particularly with the clinical observation that bypassing the proximal bowel improves type 2 diabetes and induces weight loss, a feature which, at least in part, explains the greater improvement of diabetes observed in patients undergoing a LRYGBP, for the same weight loss, compared with a pure restrictive procedure. 20 The first strictly endoluminal device used to bypass the proximal small intestine is the duodeno jejunal by- IDEN
5 IDEN 2014 A B C D Fig. 2. The POSE procedure. The POSE system, including multi-lumen device (A), Tissue approximator (B), Tissue anchor (C) and schemetic view of the stomach after treatment (D). A B Fig. 3. (A) Duodenojejunal sleeve. (B) Schematic representation of the sleeve in place in the proximal jejunum. pass (DJBS), also called "the EndoBarrier" (GI Dynamics Inc, Watertown, MA). It is composed of a self expanding implant that seats in the duodenum and has anti migration features. It is attached to a 60 cm plastic sleeve that extends into the proximal jejunum and works by creating a physical barrier between food that has been ingested and both the intestinal wall and biliopancreatic secretions (Fig. 3). The device is left in place for a maximum of 3 to 6 months and is removed with a dedicated and relatively easy system. Three trials demonstrated the potential benefit of DJBS. In the first one, 21 it was successfully deployed in 12 patients in less than 30 minutes (and required approximately 40 minutes to be removed). With the exception of pain prompting early removal, it was associated with a significant drop in HbA1C, compared with a control group. A second multicenter trial, from Chile, showed, at 12 weeks, a weight loss significantly higher in 24 patients treated with the 118 IDEN 2014
6 UGS-IV: Emerging but rarely Used Treatment Options in Asia Table 1. Available and post bariatric endotherapy technology Endoscopic procedures Mechanism Human applications Limitations Intragastric balloon Restrictive Prospective cross over study More than 2000 cases reported Patient tolerance Limited effect (6 months) Endocinch vertical gastroplasty Restrictive One prospective study (64 patients) Long term efficacy Depth of the suture TOGa Restrictive Limited human studies (33 patients) Multicentric sham pivotal trial completed Long term efficacy Restrictive procedure Gap consequences POSE Restrictive One trial (45 patients) Long term efficacy? DJBS Malabsorptive Limited efficacy on obesity, more on diabetes? Patient tolerance Long term safety & efficacy Reversibility EndoBarrier system compared to the died control group in a preoperative setting. 22 The last available study is a sham controlled trial with 24 patients treated and 13 undergoing the sham procedure, with a 12 weeks study design. Excess weight loss (11.9% versus 2.7%) and loss of more than 10% excess weight (62% versus 17% of patients) were all in favor of the DJBS. However, 7 subjects terminated earlier because of GI bleeding (N=3) or device intolerance (pain and/or vomiting, N=4), showing that the technological developments are still to be done. 23 Although these techniques still suffer from the need for the implantation of a foreign body and the limited duration of indwell, they clearly deserve further technical improvement and clinical investigation since they could be those impacting the most on co morbidities and might be of particular interest in diabetic obese patients. 20 Other implantable devices, potentially mimicking more closely RYGBP are currently in development (Valentx Inc, Carpinteria, CA) but no clinical data are currently available. Table 1 summarizes the current techniques of bariatric endotherapy for which clinical data are available. No doubt that other will come and that the role of endotherapy will be increasing in the management of bariatric patients, rendering necessary the integration of endotherapy into the armamentarium of multidisciplinary groups treating these patients. E. Transoral endoscopic restrictive implant If the duodenojejunal sleeve may be seen as the endoscopic counterpart of RYGBP, the TOGa, as the one of sleeve gastrectomy or vertical banded gastroplasty, a recently reported endoscopic implantable device (Transoral Endoscopic Restrictive Implants System (TERIS), Barosense, Redwood City, CA) may be seen as an endoscopic equivalent to gastric banding. A phase I pilot trial has been recently reported. 24 Successful placement has been achieved in 12 of 13 patients with complications (including perforation) in 3 of them. This system is obviously currently technically demanding (22 mm insertion tube, 142 min median procedural time) but an interesting excess weight los of 28% was observed at 3 months, suggesting that provided technical improvements are made, it could become another option in the endoscopic armamentarium. This procedure is associated with the placement of an implant which means that it offers the potential advantage of being removable (the drawback being like with other implants the long term durability of the procedure which will only be demonstrated by longterm follow up). The company recently closed and sold its assets to Boston Sc. IDEN
7 IDEN 2014 Revisional endoscopy after bariatric surgery Besides the primary treatment of obesity and the treatment of bariatric complications, another area of growing interest is the management of failed bariatric procedures. The RYGBP has become the most common procedure performed for the surgical treatment of morbid obesity and, therefore, encountered by gastroenterologists. Reintervention on these patients is associated with very high morbidity, in case of failure for obtaining weight loss after bariatric surgery. This failure may be attributed to dietetic problem but several anatomic factors such as staple line disruption, pouch dilation or band sleepage, may be also, at least partly, responsible. Staple line disruption resulting in gastrogastric fistula is a classical cause of weight regain in these patients. Besides the classical surgical reintervention, endoscopic suturing or fibrin glue application have been successfully reported in small series. Endoscopic suturing (Endocinch, Bard Inc USA) or volume reduction by dedicated devices (Stomaphyx, Endogastric Solutions, Seattle USA) has also been reported in patients having an enlarged pouch or anastomosis after RYGBP. 25,27 Although the currently reported series are uncontrolled, they have reported significant weight loss at follow up of 6 to 12 months. This is potentially an interesting option for patients who are at high risk of complications and often desperate after failure of bariatric surgery. Finally, while these techniques are being assessed in the setting of clinical research, Endotherapy already plays a major and established role in the management of post bariatric complications including fistulae, leaks and migrated bands and rings. 28,29 References 1. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. WHO/NUT/ NCD/98.1. WHO Technical Support Series, WHO, Geneva 1998; The World Health Organization 2005 data. Available at: Accessed September 16, Glenny AM, O Meara S, Melville A, Sheldon TA, Wilson C. The treatment and prevention of obesity: a systematic review of the literature [review]. Int J Obes Relat Metab Disord 1997;21: Magnusson M, Freedman J, Jonas E, et al. Five year results of laparoscopic vertical banded gastroplasty in the treatment of massive obesity. Obes Surg 2002;12: Zhao Y, Encinosa W. Agency for health care research and quality AHRQ. Bariatric surgery utilization and outcomes. In 1998 and Statistical Brief # 23, January Paxton J, Matthews J. The cost effectiveness of laparoscopic versus open gastric bypass surgery. Obes Surg 2005;15: Rosenthal RJ, Szomstein S, Kennedy CI, et al. Laparoscopic surgery for morbid obesity: 1,001 consecutive bariatric operations performed at The Bariatric Institute, Cleveland Clinic Florida. Obes Surg 2006;16: Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1982;1: Evans JD, Scott MH. Intragastric balloon in the treatment of patients with morbid obesity. Br J Surg 2001;88: Genco A, Cipriano M, Bacci V, et al. Bioenterics Intragastric Balloon (BIB ): a short term, double blind, randomized, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes. 2006;30: Mathus Vliegen EM, Tytgat GN. Intragastric balloon for treatment resistant obesity: safety, tolerance, and efficacy of 1 year balloon treatment followed by a 1 year balloon free follow up. Gastrointest Endosc Jan;61(1): Dastis NS, François E, Deviere J, et al. Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy Jul;41(7): Spyropoulos C, Katsakoulis E, Mead N et al. Intragastric balloon for high risk super obese patients : a prospective analysis of 120 IDEN 2014
8 UGS-IV: Emerging but rarely Used Treatment Options in Asia efficacy. Surg Obes Relat Dis 2007 ; 3 : Schwartz MP, Wellink H, Gooszen HG et al. Endoscopic gastroplication for the treatment of gastroesophageal reflux disease : a randomized sham controlled trial. Gut 2007 ; 56 : Fogel R, De Fogel J, Bonilla Y, et al. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1 year follow up in 64 patients. Gastrointest Endosc Jul;68(1): Deviere J, Ojeda Valdes G, et al. Safety, feasibility and weight loss after transoral gastroplasty: first human multicenter study. Surg Endosc 2008;22: Moreno C, Closset J, Dugardeyn S, et al. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy 2008;40: Closset J, Germanova D, Loi P, et al. Laparoscopic Gastric Bypass as a Revision Procedure After Transoral Gastroplasty. Obes Surg 2009;Dec Espinos JC, Turro R, Mata A, Cruz M, da Costa M, Villa V, Buchwald JN, Turro J. Early experience with the incisionless operative platform for the treatment of obesity: the Primary Obesity Surgery Endoluminal procedure (POSE). Obes Surg 2013;23: Rubino F, Cohen RV, Schiavon CA, et al. Duodenal jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of kg/m2: a report of 2 cases. Surg Obes Relat Dis Mar Apr;3(2): Rodriguez Grunert L, Galvao Neto MP, Alamo M, et al. First human experience with endoscopically delivered and retrieved duodenal jejunal bypass sleeve. Surg Obes Relat Dis 2008;4: Tarnoff M, Rodriguez L, Escalona A, et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal jejunal bypass sleeve versus low calorie diet for pre operative weight loss in bariatric surgery. Surg Endosc 2009;23: Gersin KS, Rothstein RI, Rosenthal RJ, et al. Open label, sham controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc Mar 19 [Epub ahead of print]. 24. de Jong K, Mathus Vliegen EMH, Veldhuyzen EAML, et al. Short term safety and efficacy of the transoral endoscopic restrictive implant system for the treatment of obesity. Gastrointest Endosc 2010;72: Obstein KL and Thompson CC. Endoscopy after bariatric surgery. Gastrointestinal Endoscopy 2009;70: Thompson CC, Slattery J, Bundga ME et al. Peroral endoscopic reduction of dilated gastro jejunal anastomosis after Roux en Y gastric bypass : a possible new option for patients with weight regain. Surg Endosc 2006;20: Mikami D, Needleman B, Narula V et al. Natural orifice surgery: initial US experience utilizing the StomaphyX device to reduce gastric pouches after Roux en Y gastric bypass. Surg Endosc 2010;24: Swinnen J, Eisendrath P, Rigaux J, Kahegeshe L, Lemmers A, Le Moine O, Devière J Self expandable metal stents for the treatment of benign upper GI leaks and perforations. Gastrointest Endosc ;73: Blero D, Eisendrath P, Vandermeeren A, Closset J, Mehdi A, Le Moine O, Devière J. Endoscopic removal of dysfunctioning bands or rings after restrictive bariatric procedures. Gastrointest Endosc ;71: IDEN
Overweight and obesity are defined as abnormal or
Imaging and Advanced Technology Ralf Kiesslich and Pankaj Jay Pasricha, Section Editors Endoscopic Options for the Treatment of Obesity MOSTAFA IBRAHIM, DANIEL BLERO, and JACQUES DEVIERE Department of
More informationRole of Malabsorptive Endoscopic Procedures in Obesity Treatment
FOCUSED REVIEW SERIES: Roles of Bariatric Endoscopy in Obesity Treatment Clin Endosc 2017;50:26-30 https://doi.org/10.5946/ce.2017.004 Print ISSN 2234-2400 On-line ISSN 2234-2443 Open Access Role of Malabsorptive
More informationDisclosure Statement. Covidien: Consultant, Grants
Disclosure Statement Covidien: Consultant, Grants Non-Invasive Bariatric Procedures Michel M. Murr, MD, FACS Director of Bariatric Surgery Metabolic and Bariatric Surgery Outline for Non-Invasive Bariatrics
More informationMetabolic Interventions and the GI Tract: Issues
Metabolic Interventions and the GI Tract: Issues Michael L. Kochman, M.D., AGAF Wilmott Family Professor of Medicine Vice-Chair of Medicine for Clinical Affairs University of Pennsylvania Health System
More informationDisclosures. Weight Regain After Bariatric Surgery & Future Therapies. Objectives
Weight Regain After Bariatric Surgery & Future Therapies Matthew Kroh, MD Assistant Professor of Surgery Cleveland Clinic Center for Surgical Innovation, Technology, and Education Digestive Disease Institute
More informationCommonly Performed Bariatric Procedures in Singapore. Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital
Commonly Performed Bariatric Procedures in Singapore Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital Scope 1. Introduction 2. Principles of bariatric surgery
More informationEndoscopie bariatrique et métabolique. Prof Guido Costamagna. DIGESTIVE ENDOSCOPY UNIT - Foundation Policlinico A. Gemelli - Rome
XVI ème Congrès National de la SMED Endoscopie bariatrique et métabolique Prof Guido Costamagna DIGESTIVE ENDOSCOPY UNIT - Foundation Policlinico A. Gemelli - Rome European Endoscopy Training Centre -
More informationObesity Management Workshop for Health Professionals
Obesity Management Workshop for Health Professionals 17 th November 2017 Dr Graeme Rich Gastroenterologist Director of Bariatrics Australia Is a procedure the magic bullet? Energy in >> Energy out Accepted
More informationEndoscopic Advances for the Management of Obesity. Obesity
Endoscopic Advances for the Management of Obesity Gregory G. Ginsberg, MD, FACG, FASGE Professor of Medicine University of Pennsylvania Perelman School of Medicine Gastroenterology Division Director of
More informationADVANCE AT YOUR OWN PACE
ADVANCE AT YOUR OWN PACE Welcome and Introductions Obesity and Its Impact on Health Surgeon Introduction Surgical Weight Loss Options AGENDA OSVALDO ANEZ, MD 28 years of experience Performed approximately
More informationHorizon Scanning Technology Prioritising Summary. Transoral gastroplasty (TOGA System) for obesity
Horizon Scanning Technology Prioritising Summary Transoral gastroplasty () for obesity Commonwealth of Australia 2010 ISBN Publications Approval Number: This work is copyright. You may download, display,
More informationClinical Study Endoscopic Revision (StomaphyX) versus Formal Surgical Revision (Gastric Bypass) for Failed Vertical Band Gastroplasty
Obesity Volume 2013, Article ID 108507, 4 pages http://dx.doi.org/10.1155/2013/108507 Clinical Study Endoscopic Revision (StomaphyX) versus Formal Surgical Revision (Gastric Bypass) for Failed Vertical
More informationWeight Loss Surgery. Outline 3/30/12. What Every GI Nurse Needs to Know. Define Morbid Obesity & its Medical Consequences. Treatments for Obesity
3/30/12 Weight Loss Surgery What Every GI Nurse Needs to Know Kenneth A Cooper, D.O. March 31, 2012 Outline Define Morbid Obesity & its Medical Consequences Treatments for Obesity Bariatric (Weight-loss)
More informationBariatric Surgery: Indications and Ethical Concerns
Bariatric Surgery: Indications and Ethical Concerns Ramzi Alami, M.D. F.A.C.S Assistant Professor of Surgery American University of Beirut Medical Center Beirut, Lebanon Nothing to Disclose Determined
More informationNOTE: This policy is not effective until May 1, To view the current policy, click here. IMPORTANT REMINDER
NOTE: This policy is not effective until May 1, 2018. To view the current policy, click here. Medical Policy Manual Surgery, Policy No. 58 Bariatric Surgery Next Review: December 2018 Last Review: January
More informationBariatric surgery: has anything changed in the last few years?
Bariatric surgery: has anything changed in the last few years? Mauro Toppino University of Turin Digestive and Colorectal Surgery Minimal Invasive Surgery Center (Head:Prof. Mario Morino) XIV Annual Conference
More informationPolicy Specific Section: April 14, 1970 June 28, 2013
Medical Policy Bariatric Surgery Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Surgery Original Policy Date: Effective Date: April 14, 1970 June 28, 2013 Definitions
More informationA Bariatric Patient in my Waiting Room: Choosing the Right Patient for the Right Operation: Bariatric Surgery Indications
A Bariatric Patient in my Waiting Room: Choosing the Right Patient for the Right Operation: Bariatric Surgery Indications Shahzeer Karmali MD FRCSC FACS Associate Professor Surgery University of Alberta
More informationBARIATRIC SURGERY AND OTHER INVASIVE TREATMENTS FOR OBESITY
Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline must be read in its
More informationBenefits of Bariatric Surgery
Benefits of Bariatric Surgery Dr Tan Bo Chuan Registrar, Department of Surgery GP Forum 27 May 2017 Improvements of Co-morbidities Type 2 diabetes mellitus Hypertension Hyperlipidemia Degenerative joint
More informationWEIGHT LOSS SURGERY A Primer on Current Options and Outcomes. Caitlin A. Halbert DO, MS, FACS, FASMBS April 5, 2018
WEIGHT LOSS SURGERY A Primer on Current Options and Outcomes Caitlin A. Halbert DO, MS, FACS, FASMBS April 5, 2018 A Little Bit About Me Bariatric Surgical Services Reflux Surgery General Surgery Overview
More informationEndobarrier: a viable alternative to gastric bypass surgery?
Endobarrier: a viable alternative to gastric bypass surgery? Dr G Longcroft-Wheaton MB, BS, MD, MRCP, Consultant Gastroenterologist, Queen Alexandra Hospital, Portsmouth, UK Professor P Bhandari MD, FRCP,
More informationMustafa W. Aman, M.D. Director, Bariatric Surgery Program Guthrie Robert Packer Hospital
09/16/2017 presented by: Mustafa W. Aman, M.D. Director, Bariatric Surgery Program Guthrie Robert Packer Hospital I have no financial disclosures pertaining to any commercial interests Describe the role
More informationSurgical Therapy for Morbid Obesity. Janeen Jordan, PGY 5 Surgical Grand Rounds April 7, 2008
Surgical Therapy for Morbid Obesity Janeen Jordan, PGY 5 Surgical Grand Rounds April 7, 28 Obesity BMI > 3 kg/m 2 Moderate 35-4 kg/m 2 Morbid >4 kg/m 2 1.7 BILLION Overweight Adults in the world 63 MILLION
More informationEndoscopic Interventions
Endoscopic Interventions Shelby Sullivan, MD Director of the Gastroenterology Metabolic and Bariatric Program University of Colorado School of Medicine Disclosures Shelby Sullivan, M.D. has financial interests
More information4/24/2015. History of Reflux Surgery. Recent Innovations in the Surgical Treatment of Reflux
Recent Innovations in the Surgical Treatment of Reflux Scott Carpenter, DO, FACOS, FACS Mercy Hospital Ardmore Ardmore, OK History of Reflux Surgery - 18 th century- first use of term heartburn - 1934-
More informationOBESITY/OVERWEIGHT. Fastest spreading disaster of the century- Bariatric Surgical treatment. By Dr. Vladimir Shchukin Consultant General Surgeon
OBESITY/OVERWEIGHT Fastest spreading disaster of the century- Bariatric Surgical treatment By Dr. Vladimir Shchukin Consultant General Surgeon Indications for surgical treatment Indication for Gastric
More informationImaging of gastric bands and their complications: an educational pictorial review
Imaging of gastric bands and their complications: an educational pictorial review Poster No.: C-1142 Congress: ECR 2014 Type: Educational Exhibit Authors: F. Moloney, M. Twomey, C. Bogue ; Cork/IE, IE,
More informationSee Policy CPT CODE section below for any prior authorization requirements
Effective Date: 9/1/2018 Section: SUR Policy No: 139 Medical Officer 9/1/2018 Date Technology Assessment Committee Approved Date: 3/04; 3/05; 3/06; 4/12; 4/16 Medical Policy Committee Approved Date: 11/08;
More informationMarc Bessler, M.D.*, Amna Daud, M.D., M.P.H., Teresa Kim, M.D., Mary DiGiorgi, M.P.H.
Surgery for Obesity and Related Diseases 3 (2007) 480 485 Original article Prospective randomized trial of banded versus nonbanded gastric bypass for the super obese: early results Marc Bessler, M.D.*,
More informationtype 2 diabetes is a surgical disease
M. Lannoo, MD, University Hospitals Leuven Walter Pories claimed in 1992 type 2 diabetes is a surgical disease Buchwald et al. conducted a large meta-analysis THE FIRST OBSERVATIONS W. Pories 500 patients
More informationBariatric Surgery: How complex is this? Pradeep Pallati, MD, FACS, FASMBS
Bariatric Surgery: How complex is this? Pradeep Pallati, MD, FACS, FASMBS Nothing to Disclose Types of Bariatric Surgery Restrictive Malabsorptive Combination Restrictive and Malabsorptive Newer Endoluminal
More informationGoals 1/9/2018. Obesity over the last decade Surgery has become a safer management strategy Surgical options for management
The Current State of Surgical Intervention in Management of Morbid Obesity Goals Obesity over the last decade Surgery has become a safer management strategy Surgical options for management 1 Goals Obesity
More informationConsidering Bariatric Surgery?
Considering Bariatric Surgery? minimally invasive LearnLearn aboutabout minimally invasive da Vinci da Vinci Surgery Surgery The Condit io n: Obesity Obesity is defined as having a body mass index (BMI)
More informationMEDICAL POLICY SUBJECT: MAGNETIC ESOPHAGEAL RING/ MAGNETIC SPHINCTER AUGMENTATION FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD)
MEDICAL POLICY SUBJECT: MAGNETIC ESOPHAGEAL RING/ MAGNETIC SPHINCTER PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial
More informationBariatric Surgery. Overview of Procedural Options
Bariatric Surgery Overview of Procedural Options The Obesity Epidemic In 1991, NO state had an obesity rate above 20% 1 As of 2010, more than two-thirds of states (38) now have adult obesity rates above
More informationDisclosure Medtronic - Speaker/ Research Grant/ Robotics Advisory Board Gore - Education Grant/ Speaker Teleflex - Consultant Da Vinci - Proctor
Sleeve Plus Options Disclosure Medtronic - Speaker/ Research Grant/ Robotics Advisory Board Gore - Education Grant/ Speaker Teleflex - Consultant Da Vinci - Proctor Mederi - Speaker Novadaq - Advisory
More informationDON T LET OBESITY SPOIL YOUR HEALTH AND YOUR LIFE
July 2015 Issue No.17 DON T LET OBESITY SPOIL YOUR HEALTH AND YOUR LIFE www.sghgroup.com JEDDAH RIYADH MEDINA ASEER HAIL SANAA DUBAI CAIRO Definitions Over View and General Facts General Key facts! Worldwide
More informationBARIATRIC SURGERY. Weight Loss Surgery. A variety of surgical procedures to reduce weight performed on people who have obesity. Therapy Male & Female
BARIATRIC SURGERY Weight Loss Surgery A variety of surgical procedures to reduce weight performed on people who have obesity. Therapy Male & Female About Bariatric surgery Bariatric surgery offers a treatment
More informationBariatric Surgery. Options & Outcomes
Bariatric Surgery Options & Outcomes Obesity Obesity now leading cause of premature death & illness in Australia 67% of Australians are overweight or obese Australia 4 th fattest nation in OECD Obesity
More informationTechnique. Matthew Bettendorf, MD Essentia Health Duluth Clinic. Laparoscopic approach One 12mm port, Four 5mm ports
Matthew Bettendorf, MD Essentia Health Duluth Clinic Technique Laparoscopic approach One 12mm port, Four 5mm ports Single staple line with no anastamosis 85% gastrectomy Goal to remove
More informationPeroral endoscopic reduction of dilated gastrojejunal anastomosis after bariatric surgery: Techniques and efficacy
Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4253/wjge.v8.i4.239 World J Gastrointest Endosc 2016 February 25; 8(4): 239-243 ISSN 1948-5190
More informationInnovative solutions in bariatric surgery
Review Article Innovative solutions in bariatric surgery Tomasz Kozlowski, Krzysztof Kozakiewicz, Jacek Dadan, Piotr Mysliwiec 1 st Department of General and Endocrinological Surgery, Medical University
More informationManaging Complications of Bariatric Surgery. Objectives
Managing Complications of Bariatric Surgery John J. Vargo, II, MD, MPH, FACG Chair, Department of Gastroenterology and Hepatology Digestive Disease and Surgery Institute Cleveland Clinic Cleveland, OH
More informationImaging findings in complications of bariatric surgery.
Imaging findings in complications of bariatric surgery. Poster No.: C-1791 Congress: ECR 2012 Type: Educational Exhibit Authors: A. Fernandez Alfonso, G. Anguita Martinez, D. C. Olivares Morello, C. García
More informationBariatric Surgery. The Oregon Bariatric Center Surgical Team
Bariatric Surgery The Oregon Bariatric Center Surgical Team Colin MacColl, MD, Medical Director, Bariatric Surgeon Jessica Folek, MD, Bariatric Surgeon I have no disclosures Disclosures Objectives What
More informationMEDICAL POLICY SUBJECT: SURGICAL MANAGEMENT OF OBESITY
MEDICAL POLICY PAGE: 1 OF: 22 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationENDOLUMINAL THERAPIES FOR GERD. University of Colorado Department of Surgery Grand Rounds March 31st, 2008
ENDOLUMINAL THERAPIES FOR GERD University of Colorado Department of Surgery Grand Rounds March 31st, 2008 Overview GERD Healthcare significance Definitions Treatment objectives Endoscopic options Plication
More informationHere are some types of gastric bypass surgery:
Gastric Bypass- Definition By Mayo Clinic staff Weight-loss (bariatric) surgeries change your digestive system, often limiting the amount of food you can eat. These surgeries help you lose weight and can
More informationSURGICAL TREATMENT FOR OBESITY: WHATS THE BEST OPTION? Natan Zundel, MD, FACS
SURGICAL TREATMENT FOR OBESITY: WHATS THE BEST OPTION? Natan Zundel, MD, FACS Professor of Surgery Vice-Chairman Department of Surgery Florida International University Herbert Wertheim College of Medicine
More informationMedicare Part C Medical Coverage Policy
Morbid Obesity Surgery Origination: June 30, 1988 Review Date: October 18, 2017 Next Review: October, 2019 Medicare Part C Medical Coverage Policy DESCRIPTION OF PROCEDURE OR SERVICE Bariatric surgery
More informationBARIATRIC SURGERY: GLOBAL MARKETS FOR SERVICES AND DEVICES. HLC153A November Dr. Ritu Thakur Dangi Project Analyst ISBN:
BARIATRIC SURGERY: GLOBAL MARKETS FOR SERVICES AND DEVICES HLC153A November 2013 Dr. Ritu Thakur Dangi Project Analyst ISBN: 1-56965-630-4 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215,
More informationBariatric Surgery. Policy Number: Last Review: 12/2018 Origination: 10/1988 Next Review: 12/2019
Bariatric Surgery Policy Number: 7.01.47 Last Review: 12/2018 Origination: 10/1988 Next Review: 12/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for bariatric surgery
More informationMEDICAL COVERAGE POLICY. SERVICE: Bariatric (Weight Loss) Surgery Policy Number: 053 Effective Date: 08/01/2017 Last Review: 05/16/2017
Important note Even though this policy may indicate that a particular service or supply is considered covered, this conclusion is not necessarily based upon the terms of your particular benefit plan. Each
More information7th International Congress of the Spanish Society of Obesity Surgery. Valladolid Spain May, 2004.
7th International Congress of the Spanish Society of Obesity Surgery. Valladolid Spain May, 2004. DIMINISHING POSTOPERATIVE RISKS OF GASTRIC BYPASS Stenosis Stenosis Leak Leak Bleeding Bleeding Stenosis
More informationLaparoscopic Adjustable Gastric Band The Safest, Effective Procedure for Treating Obesity and Obesity Related Disease
Laparoscopic Adjustable Gastric Band The Safest, Effective Procedure for Treating Obesity and Obesity Related Disease Erik Peltz, D.O. April 7 th, 2008 University of Colorado Health Science Center Department
More informationEndorsed by Executive Council June 17, American Society for Metabolic and Bariatric Surgery
Endorsed by Executive Council June 17, 2007 American Society for Metabolic and Bariatric Surgery POSITION STATEMENT ON SLEEVE GASTRECTOMY AS A BARIATRIC PROCEDURE Clinical Issues Committee Preamble. The
More informationProtocol. Bariatric Surgery
Protocol Bariatric Surgery (70147) Medical Benefit Effective Date: 04/01/18 Next Review Date: 11/18 Preauthorization No Review Dates: 04/07, 05/08, 05/09, 03/10, 03/11, 07/11, 07/12, 9/12, 05/13, 01/14,
More informationEndoscopic management of sleeve leaks
Endoscopic management of sleeve leaks Mr Damien Loh Oesophagogastric and Bariatric Surgeon The Alfred The clinical problem Incidence 0.1-7% Inpatient mortality 2-5% High morbidity Prolonged ICU and in-hospital
More informationChoice Critria in Bariatric Surgery. Giovanni Camerini
Choice Critria in Bariatric Surgery Giovanni Camerini Surgical vs Medical treatment Indications for Bariatric Surgery (WHO 1992) BMI of at least 40; BMI of 35 in case of serious diseases related to obesity;
More informationEndoscopic Therapies for Obesity: where we are and where we go?
Endoscopic Therapies for Obesity: where we are and where we go? Gregory G. Ginsberg, M.D. Professor of Medicine University of Pennsylvania Perelman School of Medicine Gastroenterology Division Director
More informationBariatric Surgery MM /11/2001. HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient; Inpatient
Bariatric Surgery Policy Number: Original Effective Date: MM.06.003 09/11/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient;
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of implantation of a duodenal jejunal bypass sleeve for managing obesity Inserting
More informationLaparoscopic Placement of Non-Adjustable Silicone Ring for Weight Regain After Roux-en-Y Gastric Bypass
OBES SURG (2009) 19:650 654 DOI 10.1007/s11695-009-9807-9 RESEARCH ARTICLE Laparoscopic Placement of Non-Adjustable Silicone Ring for Weight Regain After Roux-en-Y Gastric Bypass Giovanni Dapri & Guy Bernard
More informationThe Surgical Management of Obesity
The Surgical Management of Obesity Omar al noubani MD,MRCS وك ل وا و اش ز ب وا و ال ت س رف وا األعراف ما مأل ابن آدم وعاء شر ا من بطنه Persons who are naturally fat are apt to die earlier than those who
More informationNew endoscopic procedures for diabetes mellitus type 2 and obesity treatment
Original Article New endoscopic procedures for diabetes mellitus type 2 and obesity treatment Francesco Frattini 1, Giacomo Borroni 1, Matteo Lavazza 1, Xiaoli Liu 2, Hoon Yub Kim 3, Renbin Liu 4, Angkoon
More informationCME Post Test. D. Treatment with insulin E. Age older than 55 years
CME Post Test Translational Endocrinology & Metabolism: Metabolic Surgery Update Please select the best answer to each question on the online answer sheet. Go to http://www.endojournals.org/translational/
More informationMEDICAL POLICY SUBJECT: SURGICAL MANAGEMENT OF OBESITY. POLICY NUMBER: CATEGORY: Technology Assessment
MEDICAL POLICY SUBJECT: SURGICAL MANAGEMENT OF PAGE: 1 OF: 17 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including
More informationSESSION 6 LONG TERM OUTCOMES AND THE IMPORTANCE OF FOLLOW UP OUTCOMES OF ENDOSCOPIC PROCEDURES. Kiron Bhatia MMedSci(Surg) FRACS
SESSION 6 LONG TERM OUTCOMES AND THE IMPORTANCE OF FOLLOW UP OUTCOMES OF ENDOSCOPIC PROCEDURES Kiron Bhatia MMedSci(Surg) FRACS DISCLAIMER Consultancy for Apollo Endosurgery there is a prevalent reluctance
More informationEndoscopic vs Surgical Therapies for GERD: Is it Time to Put down the Scalpel?
Endoscopic vs Surgical Therapies for GERD: Is it Time to Put down the Scalpel? Brian R. Smith, MD, FACS, FASMBS Associate Professor of Surgery & General Surgery Residency Program Director UC Irvine Medical
More informationA pathway to endoscopic bariatric therapies
Surgery for Obesity and Related Diseases 7 (2011) 672 682 White paper A pathway to endoscopic bariatric therapies ASGE/ASMBS Task Force on Endoscopic Bariatric Therapy Preamble The American Society for
More informationMULTI-CENTER, PROSPECTIVE, CONTROLLED TRIAL OF THE DUODENAL JEJUNAL BYPASS LINER FOR THE TREATMENT OF TYPE 2 DIABETES IN OBESE PATIENTS
Bariatric endoscopy MULTI-CENTER, PROSPECTIVE, CONTROLLED TRIAL OF THE DUODENAL JEJUNAL BYPASS LINER FOR THE TREATMENT OF TYPE 2 DIABETES IN OBESE PATIENTS Marek Benes, Tomas Hucl, Pavel Drastich, Julius
More informationSURGICAL TREATMENT FOR OBESITY: WHAT S THE BEST OPTION? Natan Zundel, MD, FACS, FASMBS
SURGICAL TREATMENT FOR OBESITY: WHAT S THE BEST OPTION? Natan Zundel, MD, FACS, FASMBS Professor of Surgery Vice-Chairman Department of Surgery Florida International University Herbert Wertheim College
More informationBariatric Surgery POLICY
Bariatric Surgery POLICY The GEHA guidelines pertaining to consideration of bariatric surgery is based on the NIH Consensus Conference on Surgical Treatment of Morbid Obesity (1998) 1 which state that
More informationAdipocytes, Obesity, Bariatric Surgery and its Complications
Adipocytes, Obesity, Bariatric Surgery and its Complications Daniel C. Morris, MD, FACEP, FAHA Senior Staff Physician Department of Emergency Medicine Objectives Basic science of adipocyte Adipocyte tissue
More informationGuiding Principles. Trans-oral Incisionless Fundoplication (TIF) for GERD: When, Why & How 4/6/18
Gastroesophageal Reflux Disease Shaping the Future of GERD Management Treating patients with the TIF procedure using the EsophyX device (EndoGastric Solutions) Gonzalo Pandolfi, MD Trans-oral Incisionless
More informationMedical Policy. MP Bariatric Surgery. BCBSA Ref. Policy: Last Review: 02/26/2018 Effective Date: 02/26/2018 Section: Surgery
Medical Policy MP 7.01.47 BCBSA Ref. Policy: 7.01.47 Last Review: 02/26/2018 Effective Date: 02/26/2018 Section: Surgery Related Policies 2.01.38 Transesophageal Endoscopic Therapies for Gastroesophageal
More informationEndoscopic Bariatric/Metabolic Surgery
375 Daanish Kazi, DO 1 Leena Khaitan, MD, MPH, FASMBS 1 1 University Hospitals, Cleveland Medical Center, Cleveland, Ohio Dig Dis Interv 2018;2:375 382. Address for correspondence Leena Khaitan, MD, MPH,
More informationBARIATRIC SURGERY. Policy Number: 2016M0067B Effective Date: September 1, Table of Contents: Page: Cross Reference Policy:
BARIATRIC SURGERY Policy Number: 2016M0067B Effective Date: September 1, 2016 Table of Contents: Page: Cross Reference Policy: POLICY DESCRIPTION 2 Gastric Electrical Stimulation for COVERAGE RATIONALE/CLINICAL
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation. See specific types, e.g., Thermal ablation Achalasia, 53 75 described, 53 features of, 53 management of past options, 54 POEM
More informationMedical Coverage Policy Bariatric Surgery EFFECTIVE DATE: POLICY LAST UPDATED:
Medical Coverage Policy Bariatric Surgery EFFECTIVE DATE: 11 04 2014 POLICY LAST UPDATED: 07 17 2018 OVERVIEW Surgery for obesity, termed bariatric surgery, is a treatment for morbid obesity in patients
More informationBariatric Surgery: A Cost-effective Treatment of Obesity?
Bariatric Surgery: A Cost-effective Treatment of Obesity? Shaneeta M. Johnson MD FACS FASMBS 2018 NMA Professional Development Seminar Congressional Black Caucus Foundation Annual Legislative Conference
More informationInternational Health Brief
International Health Brief Bariatric Surgery In this Health Brief, we look at the growing utilization of bariatric surgery as a means of achieving rapid weight loss, and consider if it should be covered
More informationAn Improved Intragastric Balloon Procedure Using a New Balloon: Preliminary Analysis of Safety and Efficiency
OBES SURG (2009) 19:237 242 DOI 10.1007/s11695-008-9592-x RESEARCH ARTICLE An Improved Intragastric Balloon Procedure Using a New Balloon: Preliminary Analysis of Safety and Efficiency Gustavo L. Carvalho
More informationOriginal Policy Date
MP 7.01.35 Bariatric Surgery Medical Policy Section Surgery Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to Medical Policy Index Disclaimer
More informationSreeni Jonnalagadda, MD., FASGE Professor of Medicine, UMKC Director of Interventional Endoscopy Saint Luke s Hospital, Kansas City
Sreeni Jonnalagadda, MD., FASGE Professor of Medicine, UMKC Director of Interventional Endoscopy Saint Luke s Hospital, Kansas City Peptic stricture Shtki Schatzki s ring Esophageal cancer Radiation therapy
More informationBariatric Surgery Corporate Medical Policy
Bariatric Surgery Corporate Medical Policy File name: Bariatric Surgery File code: UM.SURG.01 Origination: 07/2008 Last Review: 06/2018 Next Review: 06/2019 Effective Date: 10/01/2018 Description/Summary
More informationBariatric Surgery. Policy Number: Last Review: 3/2014 Origination: 10/1988 Next Review: 12/2014
Bariatric Surgery Policy Number: 7.01.47 Last Review: 3/2014 Origination: 10/1988 Next Review: 12/2014 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for bariatric surgery
More informationGastrointestinal Surgery for Severe Obesity 2.0 Contact Hours Presented by: CEU Professor
Gastrointestinal Surgery for Severe Obesity 2.0 Contact Hours Presented by: CEU Professor 7 www.ceuprofessoronline.com Copyright 8 2007 The Magellan Group, LLC All Rights Reserved. Reproduction and distribution
More informationConsidering Bariatric Surgery? Learn about minimally invasive da Vinci Surgery
Considering Bariatric Surgery? Learn about minimally invasive da Vinci Surgery The Surgery: Bariatric Surgery There are many non-surgical treatments for obesity such as dieting, exercise, and medicine.
More informationThe Bariatric and Heartburn Center of Northeast Ohio
The Bariatric and Heartburn Center of Northeast Ohio A message from Dr. Chlysta: Walter J. Chlysta MD, FACS, FASMBS 1900 23 rd Street, Suite 403 Cuyahoga Falls, OH 44223 Phone 330-926-3443 Fax 330-255-5092
More informationMEDICAL POLICY DRAFT MEDICAL POLICY DETAILS POLICY STATEMENT. Page: 1 of 18
Page: 1 of 18 MEDICAL POLICY DRAFT MEDICAL POLICY DETAILS Medical Policy Title SURGICAL MANAGEMENT OF OBESITY Policy Number 7.01.29 Category Technology Assessment Effective Date 05/18/00 Revised Date 03/21/02,
More informationMEDICAL POLICY SUBJECT: SURGICAL MANAGEMENT OF OBESITY. POLICY NUMBER: CATEGORY: Technology Assessment
MEDICAL POLICY SUBJECT: SURGICAL MANAGEMENT OF PAGE: 1 OF: 25 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationChapter 4 Section 13.2
TRICARE Policy Manual 6010.60-M, April 1, 2015 Surgery Chapter 4 Section 13.2 Issue Date: November 9, 1982 Authority: 32 CFR 199.2(b) and 32 CFR 199.4(e)(15) Copyright: CPT only 2006 American Medical Association
More informationGastric bypass vs. Sleeve gastrectomy
Gastric bypass vs. Sleeve gastrectomy SLEEVEPASS-study Sleeve gastrectomy Paulina Salminen, M.D., PhD Turku University Hospital Department of Surgery Stockholms Obesitasdagar 19.4.2012 Swedish Obese Subjects
More informationBARIATRIC SURGERY. Status Active. Medical and Behavioral Health Policy Section: Surgery Policy Number: IV-19 Effective Date: 10/20/2014.
Status Active Medical and Behavioral Health Policy Section: Surgery Policy Number: IV-19 Effective Date: 10/20/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members should
More informationOBESITY MANAGEMENT: DIET/EXERCISE, NEW DRUGS AND/OR SURGERY?
OBESITY MANAGEMENT: DIET/EXERCISE, NEW DRUGS AND/OR SURGERY? ERIC VOLCKMANN, MD DIRECTOR OF BARIATRIC SURGERY OCTOBER 20, 2017 OBJECTIVES Define prevalence and health effects of obesity Discuss different
More informationEndoscopic biodegradable stents as a rescue treatment in the management of post bariatric surgery leaks: acaseseries
Endoscopic biodegradable stents as a rescue treatment in the management of post bariatric surgery leaks: acaseseries Authors Abed Al Lehibi, Areej Al Balkhi, Abdullah Al Mtawa, Nawaf Al Otaibi Institution
More informationBradley J. Needleman, MD, FACS Associate Professor of Clinical Surgery
Bariatric Surgery: Current Status Bradley J. Needleman, MD, FACS Associate Professor of Clinical Surgery Director, Bariatric Surgery Program Center for Minimally Invasive Surgery The Ohio State University
More information